LeadIQ logo
Learn more at LeadIQ.com

Insights

Pipeline Expansion Terns Pharmaceuticals is developing a diverse portfolio of small-molecule product candidates targeting serious diseases like oncology and obesity, which presents sales opportunities for pharmaceutical products addressing unmet medical needs.

Strategic Events Participation The company actively participates in industry events such as the European Hematology Association Congress and Oppenheimer Healthcare Life Sciences Conference, providing excellent networking opportunities and potential collaborations for sales growth.

Top Talent Recruitment Terns Pharmaceuticals has recently appointed key personnel like Robert Azelby as Board of Directors and Andrew Gengos as Chief Financial Officer, showcasing a commitment to leadership excellence that can enhance credibility in sales interactions.

Competitive Positioning With a focus on developing innovative small-molecule therapies and a strong financial base supported by funding of $150M, Terns Pharmaceuticals stands out among similar companies, offering a competitive edge to drive sales success.

Market Presence Expansion As Terns Pharmaceuticals continues to expand its team with experienced professionals like Scott Harris as Chief Development Officer, the company's enhanced capabilities can lead to the development of new products and increased market presence, creating additional avenues for sales growth.

Terns Pharmaceuticals Tech Stack

Terns Pharmaceuticals uses 8 technology products and services including Akamai, WordPress, Indeed, and more. Explore Terns Pharmaceuticals's tech stack below.

  • Akamai
    Content Delivery Network
  • WordPress
    Content Management System
  • Indeed
    Human Resource Management System
  • jQuery
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Acquia Cloud Platform
    Platform As A Service
  • MediaElement.js
    Video Players
  • Google Analytics
    Web Analytics

Media & News

Terns Pharmaceuticals's Email Address Formats

Terns Pharmaceuticals uses at least 1 format(s):
Terns Pharmaceuticals Email FormatsExamplePercentage
FLast@ternspharma.comJDoe@ternspharma.com
45%
Last@ternspharma.comDoe@ternspharma.com
10%
FLast@ternspharma.comJDoe@ternspharma.com
45%

Frequently Asked Questions

Where is Terns Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconTerns Pharmaceuticals's main headquarters is located at 1065 E Hillsdale Blvd Suite 100 Foster City, California 94404 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Terns Pharmaceuticals's stock symbol?

Minus sign iconPlus sign iconTerns Pharmaceuticals is a publicly traded company; the company's stock symbol is TERN.

What is Terns Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconTerns Pharmaceuticals's official website is ternspharma.com and has social profiles on LinkedIn.

How much revenue does Terns Pharmaceuticals generate?

Minus sign iconPlus sign icon As of June 2025, Terns Pharmaceuticals's annual revenue reached $35M.

What is Terns Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconTerns Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Terns Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of June 2025, Terns Pharmaceuticals has approximately 62 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: S. S.Chief Executive Officer: A. B.Chief Business Officer: M. S. J.. Explore Terns Pharmaceuticals's employee directory with LeadIQ.

What industry does Terns Pharmaceuticals belong to?

Minus sign iconPlus sign iconTerns Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Terns Pharmaceuticals use?

Minus sign iconPlus sign iconTerns Pharmaceuticals's tech stack includes AkamaiWordPressIndeedjQueryMicrosoft WordAcquia Cloud PlatformMediaElement.jsGoogle Analytics.

What is Terns Pharmaceuticals's email format?

Minus sign iconPlus sign iconTerns Pharmaceuticals's email format typically follows the pattern of . Find more Terns Pharmaceuticals email formats with LeadIQ.

How much funding has Terns Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of June 2025, Terns Pharmaceuticals has raised $150M in funding. The last funding round occurred on Sep 10, 2024 for $150M.

When was Terns Pharmaceuticals founded?

Minus sign iconPlus sign iconTerns Pharmaceuticals was founded in 2017.
Terns Pharmaceuticals

Terns Pharmaceuticals

Biotechnology ResearchCalifornia, United States51-200 Employees

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com.

Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated otherwise.

Section iconCompany Overview

Headquarters
1065 E Hillsdale Blvd Suite 100 Foster City, California 94404 US
Website
ternspharma.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TERN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $150M

    Terns Pharmaceuticals has raised a total of $150M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $150M.

  • $10M$50M

    Terns Pharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $150M

    Terns Pharmaceuticals has raised a total of $150M of funding over 6 rounds. Their latest funding round was raised on Sep 10, 2024 in the amount of $150M.

  • $10M$50M

    Terns Pharmaceuticals's revenue is in the range of $10M$50M

Company Leadership

  • Stylized image of a person
    S. S.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. B.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. S. J.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. K.
    Chief Legal Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. K.
    Chief Medical Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    E. M.
    Senior Executive Assistant, Office Of The Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. Y.
    Chief Operating Officer & General Counsel
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. Z.
    Founder, Director And Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    Svp, Medical Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. J.
    Senior Vice President, Research
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.